th17 cells transdifferentiate regulatory t cells resolution inflammation
inflammation beneficial host response infection can contribute inflammatory disease unregulated th17 lineage t helper th cells can cause severe human inflammatory diseases cells exhibit instability can cease express signature cytokine il-17a plasticity can start expressing cytokines typical lineages upon vitro re-stimulation however technical limitations prevented transcriptional profiling pre post-conversion th17 cells ex vivo immune responses thus unknown whether th17 cell plasticity merely reflects change expression cytokines th17 cells physiologically undergo global genetic reprogramming driving conversion one t helper cell type another process known transdifferentiation furthermore although th17 cell instability/plasticity associated pathogenicity unknown whether present therapeutic opportunity whereby formerly pathogenic th17 cells adopt anti-inflammatory fate used two new fate-mapping mouse models track th17 cells immune responses show cd4+ t cells formerly expressed il-17a go acquire anti-inflammatory phenotype transdifferentiation th17 regulatory t cells illustrated change signature transcriptional profile acquisition potent regulatory capacity comparisons transcriptional profiles pre-and post-conversion th17 cells also revealed role canonical tgf-beta signalling consequently aryl hydrocarbon receptor ahr conversion thus th17 cells transdifferentiate regulatory cells contribute resolution inflammation data suggest th17 cell instability plasticity therapeutic opportunity inflammatory diseases
